Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-05-31-Speech-3-174"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20060531.16.3-174"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"It is good that we have recognised the need to test children’s medicine specifically for children. Once this principle is established we must go further to refine testing. Childhood is not static. The biology of a baby is quite different from the biology of a teenager.
We must also insist on periodic scientific reviews. The long-term effects on children must be studied not just to look at accumulative effect, as we do with adult medicines, but to look at the particular effect the medicine has at different stages of a child’s development and on the health of the young adult they become.
Ritalin is the most widely prescribed drug for children in the US. Only now, after almost 20 years of use, have we realised the permanent damage Ritalin has done to the development of the cardiovascular system of the young adult the child user becomes. Thousands, even millions of adults will face adulthood with cardiovascular disease from a paediatric medicine tested for its effect on behaviour, not hearts.
Scientific testing must be specific, in this case for children, and must be updated. Otherwise, we find out the bad news when it is too late."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples